Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines

Background: Currently, the immunogenicity of influenza vaccines is assessed by detecting an increase of hemagglutination inhibition (HI) antibodies. As neuraminidase (NA)-based immunity may be significant in protecting against influenza infection, detection of neuraminidase inhibiting (NI) antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Desheva, Yulia, Smolonogina, Tatiana, Donina, Svetlana, Rudenko, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344733/
https://www.ncbi.nlm.nih.gov/pubmed/32485797
http://dx.doi.org/10.3390/antib9020020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344733/
https://www.ncbi.nlm.nih.gov/pubmed/32485797
http://dx.doi.org/10.3390/antib9020020

Ejemplares similares